Agilent/Dako

Melan A, Melanoma Antigen Recognized by T-Cells

#M7196 · western blot

48
Citing papers
1k
Combined citations
Supplier page Find this product

Research areas

Cutaneous Melanoma Detection and Management9Melanoma and MAPK Pathways8Immunotherapy and Immune Responses7Ocular Oncology and Treatments6Cancer Cells and Metastasis6melanin and skin pigmentation5Cancer Mechanisms and Therapy3Cancer Immunotherapy and Biomarkers3

Papers citing this product

1
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
Nature·2017·161 cit.·DOI
2
Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability
Genome biology·2016·103 cit.·DOI
3
P16INK4a Positive Cells in Human Skin Are Indicative of Local Elastic Fiber Morphology, Facial Wrinkling, and Perceived Age
The Journals of Gerontology Series A·2015·86 cit.·DOI
4
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Journal for ImmunoTherapy of Cancer·2019·85 cit.·DOI
5
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo
JCI Insight·2020·67 cit.·DOI
6
Human Breast Cancer Cell Lines Co-Express Neuronal, Epithelial, and Melanocytic Differentiation Markers In Vitro and In Vivo
PLoS ONE·2010·52 cit.·DOI
7
Testicular lipomatosis in Cowden's syndrome
Modern Pathology·2005·46 cit.·DOI
8
Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions
British Journal of Ophthalmology·2006·43 cit.·DOI
9
Immunophenotypic Differences Between Uveal and Cutaneous Melanomas
Archives of Ophthalmology·2002·42 cit.·DOI
10
GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin
Scientific Reports·2020·37 cit.·DOI
Melan A, Melanoma Antigen Recognized by T-Cells — Evidence — PubIndex